The Updated WHO Classification of Hematological Malignancies
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
A summary Received: 22 January 2016 / Revised: 8 February 2016 / Accepted: 9 February 2016 / Published online: 9 May 2016 © Springer-Verlag Berlin Heidelberg 2016
CASE N°50 from https://icytology.wordpress.com
From Pathology – Research and Practice 212 (2016) 583–597 pp.
Its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy
Head and Neck Pathol (2016) 10:75–84 DOI 10.1007/s12105-016-0695-8
This publication, in an attempt to reflect the polytonal vibrancy of European pathology, has come to include a variety of sections and an increasing number of pages. ESP Newsletter Summer Edition 2016 is here!
June 6-8, 2016 in Varna took place European School of Pathology – Update in Thyroid Pathology for Pathologist. The course is designated for (two days and half) with European CME Credits – 20 (ECMEC)
Background: Autophagy is a catabolic process that has a vital role in cancer progression and treatment. Current chemotherapeutic agents, which target autophagy, result in growth inhibition in many cancer types. In this study, we examined the role of autophagy in breast cancer (BCa) patients as well as BCa cell lines. Methods: Tissue microarray was used to detect the expression of an autophagy marker, LC3B in BCa patients (normal/ hyperplasia ¼ 8; grade-I ¼ 15, grade-II ¼ 84, and grade-III ¼…